Strategies to Improve Coverage of Typhoid Conjugate Vaccine (TCV) Immunization Campaign in Karachi, Pakistan

Farah Naz Qamar, Rabab Batool, Sonia Qureshi, Miqdad Ali, Tahira Sadaf, Junaid Mehmood, Khalid Iqbal, Akram Sultan, Noah Duff, Mohammad Tahir Yousafzai, Farah Naz Qamar, Rabab Batool, Sonia Qureshi, Miqdad Ali, Tahira Sadaf, Junaid Mehmood, Khalid Iqbal, Akram Sultan, Noah Duff, Mohammad Tahir Yousafzai

Abstract

The emergence and spread of extensively drug-resistant (XDR) typhoid in Karachi, Pakistan led to an outbreak response in Lyari Town, Karachi utilizing a mass immunization campaign with typhoid conjugate vaccine (TCV), Typbar TCV®. The mass immunization campaign, targeted Lyari Town, Karachi, one of the worst affected towns during the XDR typhoid outbreak. Here we describe the strategies used to improve acceptance and coverage of Typbar TCV in Lyari Town, Karachi. The mass immunization campaign with Typbar TCV was started as a school- and hospital-based vaccination campaign targeting children between the age of 6 months to 15 years old. A dose of 0.5 mL Typbar TCV was administered intramuscularly. A mobile vaccination campaign was added to cope with high absenteeism and non-response from parents in schools and to cover children out of school. Different strategies were found to be effective in increasing the vaccination coverage and in tackling vaccine hesitancy. Community engagement was the most successful strategy to overcome refusals and helped to gain trust in the newly introduced vaccine. Community announcements and playing typhoid jingles helped to increase awareness regarding the ongoing typhoid outbreak. Mop-up activity in schools was helpful in increasing coverage. Networking with locally active groups, clubs and community workers were found to be the key factors in decreasing refusals.

Keywords: extensively drug-resistant typhoid; mass immunization campaign; outbreak; typhoid conjugate vaccine.

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Estimated Coverage of Typbar TCV among children 6 months to 15 years of age in Lyari Town.

References

    1. Harris J.B., Brooks W.A. Hunter’s Tropical Medicine and Emerging Infectious Diseases. Elsevier; Amsterdam, The Netherlands: 2020. Typhoid and paratyphoid (enteric) fever; pp. 608–616.
    1. Crump J.A. Progress in typhoid fever epidemiology. Clin. Infect. Dis. 2019;68:S4–S9. doi: 10.1093/cid/ciy846.
    1. Meiring J.E., Sambakunsi R., Moyo E., Misiri T., Mwakiseghile F., Patel P., Patel P., Ndaferankhande J., Laurens M.B., Gooding K., et al. Community Engagement before Initiation of Typhoid Conjugate Vaccine Trial in Schools in Two Urban Townships in Blantyre, Malawi: Experience and Lessons. Clin. Infect. Dis. 2019;68:S146–S153. doi: 10.1093/cid/ciy1110.
    1. Stanaway J.D., Reiner R.C., Blacker B.F., Goldberg E.M., Khalil I.A., Troeger C.E., Andrews J.R., Bhutta Z.A., Crump J.A., Im J., et al. The global burden of typhoid and paratyphoid fevers: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Infect. Dis. 2019;19:369–381. doi: 10.1016/S1473-3099(18)30685-6.
    1. Browne A.J., Hamadani B.H.K., Kumaran E.A.P., Rao P., Longbottom J., Harriss E., Moore C.E., Dunachie S., Basnyat B., Baker S., et al. Drug-resistant enteric fever worldwide, 1990 to 2018: A systematic review and meta-analysis. BMC Med. 2020;18:1. doi: 10.1186/s12916-019-1443-1.
    1. Qamar F.N., Yousafzai M.T., Sultana S., Baig A., Shakoor S., Hirani F., Wassay A., Khushboo S., Mehmood J., Freeman A., et al. A retrospective study of laboratory-based enteric fever surveillance, Pakistan, 2012–2014. J. Infect. Dis. 2018;218:S201–S205. doi: 10.1093/infdis/jiy205.
    1. Klemm E.J., Shakoor S., Page A.J., Qamar F.N., Judge K., Saeed D.K., Wong V.K., Dallman T.J., Nair S., Baker S., et al. Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins. MBio. 2018;9:e00105-18. doi: 10.1128/mBio.00105-18.
    1. Islamabad. [(accessed on 23 May 2020)]; Available online: .
    1. Khan M.I., Franco-Paredes C., Sahastrabuddhe S., Ochiai R.L., Mogasale V., Gessner B.D. Barriers to typhoid fever vaccine access in endemic countries. Res. Rep. Trop. Med. 2017;8:37. doi: 10.2147/RRTM.S97309.
    1. WHO . Weekly epidemiological record Relevé épidémiologique hebdomadaire. Volume 83. WHO; Geneva, Switzerland: 2008. pp. 373–384.
    1. Qamar F.N., Yousafzai M.T., Khaliq A., Karim S., Memon H., Junejo A., Baig I., Rahman N., Bhurgry S., Afroz H., et al. Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan. Vaccine. 2020;38:3518–3523. doi: 10.1016/j.vaccine.2020.03.028.
    1. Shaikh B.T., Haq Z., Tran N., Hafeez A. Health system barriers and levers in implementation of the Expanded Program on Immunization (EPI) in Pakistan: An evidence informed situation analysis. Public Health Rev. 2018;39:1–10. doi: 10.1186/s40985-018-0103-x.
    1. Gurnani V., Haldar P., Aggarwal M.K., Das M.K., Chauhan A., Murray J., Arora N.K., Jhalani M., Sudan P. Improving vaccination coverage in India: Lessons from Intensified Mission Indradhanush, a cross-sectoral systems strengthening strategy. BMJ. 2018;363:k4782. doi: 10.1136/bmj.k4782.
    1. Pugliese-Garcia M., Heyerdahl L.W., Mwamba C., Nkwemu S., Chilengi R., Demolis R., Guillermet E., Sharma A. Factors influencing vaccine acceptance and hesitancy in three informal settlements in Lusaka, Zambia. Vaccine. 2018;36:5617–5624. doi: 10.1016/j.vaccine.2018.07.042.
    1. Fournet N., Mollema L., Ruijs W.L., Harmsen I.A., Keck F., Durand J.Y., Cunha M.P., Wamsiedel M., Reis R., French J., et al. Under-vaccinated groups in Europe and their beliefs, attitudes and reasons for non-vaccination; two systematic reviews. BMC Public Health. 2018;18:196. doi: 10.1186/s12889-018-5103-8.
    1. Viqar S. Constructing Lyari: Place, governance and identity in a Karachi neighbourhood. South Asian Hist. Cult. 2014;5:365–383. doi: 10.1080/19472498.2014.905335.
    1. Considered to be One of the Most Desperate Slum Areas in South Asia, Lyari Is also the Oldest Locality of Pakistan’s Sprawling, Unpredictable and Edgy Metropolis, Karachi. [(accessed on 28 March 2020)]; Available online: .
    1. Baloch N., Rehman M. Water Scarcity in Lyari Town-Real or Manmade: A Case Study. [(accessed on 16 June 2020)]; Available online: .
    1. Mara D., Lane J., Scott B., Trouba D. Sanitation and health. PLoS Med. 2010;7:e1000363. doi: 10.1371/journal.pmed.1000363.
    1. Ferdous F., Das S.K., Ahmed S., Farzana F.D., Malek M.A., Das J., Latham J.R., Faruque A.S.G., Chisti M.J. Diarrhoea in slum children: Observation from a large diarrhoeal disease hospital in Dhaka, Bangladesh. Trop. Med. Int. Health. 2014;19:1170–1176. doi: 10.1111/tmi.12357.
    1. WHO . Safety of Mass Immunization Campaigns. WHO; Geneva, Switzerland: 2002.
    1. Jarrett C., Wilson R., O’Leary M., Eckersberger E., Larson H.J. Strategies for addressing vaccine hesitancy—A systematic review. Vaccine. 2015;33:4180–4190. doi: 10.1016/j.vaccine.2015.04.040.
    1. Berlier M., Barry R., Shadid J., Sirica C., Brunier A., Hasan H., Bouma E. Communication challenges during the development and introduction of a new meningococcal vaccine in Africa. Clin. Infect. Dis. 2015;61:S451–S458. doi: 10.1093/cid/civ493.
    1. Jauregui B., Garcia A.G.F., Janusz C.B., Blau J., Munier A., Atherly D., Mvundura M., Hajjeh R., Lopman B., Clark A.D., et al. Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group’s experience. Vaccine. 2015;33:A28–A33. doi: 10.1016/j.vaccine.2014.10.090.
    1. Hardt K., Bonanni P., King S., Santospreciado J.I., El-Hodhod M., Zimet G.D., Preiss S. Vaccine strategies: Optimising outcomes. Vaccine. 2016;34:6691–6699. doi: 10.1016/j.vaccine.2016.10.078.
    1. Patel P., Patel P., Meiring J.E., Misiri T., Mwakiseghile F., Gordon M.A. On the Ground in Malawi-First Typhoid Conjugate Vaccine Study in Africa. Am. J. Trop. Med. Hyg. 2019;100:1299–1300. doi: 10.4269/ajtmh.19-0014.
    1. Shikuku D.N., Muganda M., Amunga S.O., Obwanda E.O., Muga A., Matete T., Kisia P. Door-to-door immunization strategy for improving access and utilization of immunization Services in Hard-to-Reach Areas: A case of Migori County, Kenya. BMC Public Health. 2019;19:1064. doi: 10.1186/s12889-019-7415-8.
    1. Cooper E., O’Reilly M. A novel staff vaccination strategy. Infect. Control Hosp. Epidemiol. 2002;23:232–233. doi: 10.1086/503459.
    1. Vaccine Services. [(accessed on 30 September 2020)]; Available online:
    1. Baggio S., Gétaz L. Current Gaps in Vaccination Coverage: A Need to Improve Prevention and Care. Springer; Berlin/Heidelberg, Germany: 2019.
    1. Anderson E.L. Recommended solutions to the barriers to immunization in children and adults. Mo. Med. 2014;111:344.
    1. Mahase E. Vaccination Uptake: Access Is Still Biggest Barrier, Experts Warn. BMJ Publishing Group; London, UK: 2019.
    1. Paterson P.F., Meurice L.R., Stanberry S., Glismann S.L. Vaccine hesitancy and healthcare providers. Vaccine. 2016;34:6700–6706. doi: 10.1016/j.vaccine.2016.10.042.
    1. Smailhodzic E., Hooijsma W., Boonstra A., Langley D.J. Social media use in healthcare: A systematic review of effects on patients and on their relationship with healthcare professionals. BMC Health Serv. Res. 2016;16:442. doi: 10.1186/s12913-016-1691-0.
    1. Nguyen H.T.L., Nakamura K., Seino K. Association between a wider availability of health information and health care utilization in Vietnam: Cross-sectional study. J. Med. Internet Res. 2017;19:e405. doi: 10.2196/jmir.8328.
    1. Kolff C.A., Scott V.P., Stockwell M.S. The use of technology to promote vaccination: A social ecological model based framework. Hum. Vaccines Immunother. 2018;14:1636–1646. doi: 10.1080/21645515.2018.1477458.
    1. Kazi A., Murtaza A., Khoja S., Zaidi A., Ali S. Monitoring polio supplementary immunization activities using an automated short text messaging system in Karachi, Pakistan. Bull. World Health Organ. 2013;92:220–225. doi: 10.2471/BLT.13.122564.
    1. Morris J., Wang W., Wang L., Peddecord K.M., Sawyer M.H. Comparison of reminder methods in selected adolescents with records in an immunization registry. J. Adolesc. Health. 2015;56:S27–S32. doi: 10.1016/j.jadohealth.2015.01.010.
    1. Brown V.B., Oluwatosin O.A. Feasibility of implementing a cellphone-based reminder/recall strategy to improve childhood routine immunization in a low-resource setting: A descriptive report. BMC Health Serv. Res. 2017;17:703. doi: 10.1186/s12913-017-2639-8.
    1. Gaglani M., Riggs M., Kamenicky C., Glezen W.P. A computerized reminder strategy is effective for annual influenza immunization of children with asthma or reactive airway disease. Pediatr. Infect. Dis. J. 2001;20:1155–1160. doi: 10.1097/00006454-200112000-00012.
    1. Esposito S., Pelucchi C., Tel F., Chiarelli G., Sabatini C., Semino M., Marseglia G.L., De Mattia D., Principi N. Factors conditioning effectiveness of a reminder/recall system to improve influenza vaccination in asthmatic children. Vaccine. 2009;27:633–635. doi: 10.1016/j.vaccine.2008.11.043.
    1. Hofstetter A.M., Durivage N., Vargas C.Y., Camargo S., Vawdrey D.K., Fisher A., Stockwell M.S. Text message reminders for timely routine MMR vaccination: A randomized controlled trial. Vaccine. 2015;33:5741–5746. doi: 10.1016/j.vaccine.2015.09.042.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe